Global Biological Sample Handling Market 2025-2035

Description

List of Tables

Biological Sample Handling Market Size, Share & Trends Analysis Report by Storage Type (Cold Storage, and Room Temperature Storage), by Application (Drug Discovery, Forensic Investigation, DNA Extraction, Proteomics, and Genomics Studies, and Others), and by Ownership Type (Commercial, Academics/Research), Forecast Period 2025-2035

Industry Overview

Biological sample handling market was valued at $15.2 billion in 2024 and is projected to grow at a CAGR of 7.8%, reaching $45.6 billion by 2035. The biological sample handling market is evolving, driven by the growing need for precise sample preservation to support future diagnostic accuracy. Advances in cold chain logistics and automation have significantly enhanced the integrity of samples during transport and storage. Companies such as Thermo Fisher Scientific have provided advanced cryopreservation methods to support the growing demand. Hamilton Company has solutions, including automated storage systems for various specimen types that make aspects of the management process automated and limit contamination risk along the way. As personalized medicine continues to grow, demand for reliable handling of tissue and blood (and other clinical samples) continues to expand. Research facilities are adopting highly scalable, high-throughput storage solutions.

Market Dynamics

Automation and Robotics Integration

The global biological sample handling market is growing rapidly, driven by the increasing adoption of automation and robotics in laboratories. The laboratories are implementing more automated processes and devices to minimize errors, improve consistency, and scale up sample throughput. Labs are integrating advanced robotic systems into their workflows. Robots are mainly effective for repetitive tasks such as container labeling, liquid handling, and sample storage that were traditionally performed manually. These automated systems enable more precise, faster, and reliable sample management, ensuring the safe preservation of biological materials. Robotic platforms are especially advantageous in high-throughput environments, where they deliver exceptional accuracy and reproducibility. Furthermore, automation facilitates seamless data capture and integration with laboratory information systems, streamlining operations and improving overall efficiency.

Expansion of Global Bio-banking Networks

The global biological sample handling market is gaining momentum as bio-banking networks expand across regions. Large-scale population studies and long-term research ambition demand the organized collection and preservation of different biological samples. This growing need has led to the establishment of well-equipped bio repositories with advanced storage and retrieval systems. Consistency in sample quality across institutions is vital for collaborative research and the data community. As international research increases, formalizing sample conduct practices has evolved into a precedent. Investments in bio-banking structures are rising, particularly in emerging economies aiming to strengthen their biomedical exploration capabilities.

Market Segmentation

Based on the storage type, the market is segmented into cold storage and room temperature storage.
Based on the application, the market is segmented into drug discovery, forensic investigation, DNA extraction, proteomics and genomics studies, and others.
Based on the ownership, the market is segmented into commercial and academic/research.

Cold Storage Segment to Lead the Market with the Largest Share

As the need for cold storage solutions increases, the market for biological sample handling is expanding. Maintaining the safety of biological samples is crucial as research in areas such as proteomics, genomics, and clinical diagnostics grows. Cold storage systems play a vital role in maintaining the stability and longevity of sensitive materials such as blood, DNA, and other biospecimens. Many groups are investing in advanced freezers and systems that keep samples at very cold temperatures to make sure they stay high-quality and support research. Rules and norms for keeping samples safe highlight how important it is to have a reliable cold storehouse. For instance, Eppendorf, a company that's well-known in this field, produces the CryoCube F740 series - freezers that perform well, use lower energy, and are generally used in exploration labs.

Drug Discovery: A Key Segment in Market Growth

The growth of the biological sample handling market is strongly impacted by the added focus on drug discovery. As pharmaceutical and biotech companies enhance expenditures to develop targeted therapeutics, the need for precise and impurity-free care of natural samples is essential. Sample integrity is critical in early-stage exploration, where indeed minor diversions can affect the outgrowth of medicine efficacy studies. Effective sample processing enables brisk identification of implicit medicine campaigners and accelerates the transition from laboratory to clinical trial. Advanced systems support the running of different sample types, including blood, serum, and cultured cells. For instance, Tecan Fluent Laboratory robotization results in a more efficient sample preparation process for bioanalysis and high-throughput screening. This type of technology ensures reproducibility and data accuracy across complex workflows.

Regional Outlook

The global biological sample handling market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Growing Scientific Research and Healthcare Advancements in Europe

The European biological sample handling market is rising as governments invest heavily in scientific research and advancements in healthcare. Countries in the region, such as Germany, the UK, and France, are using government investment to conduct clinical trials and develop biobanking systems. The region is characterized by stringent ethical standards, robust sample tracking frameworks, and strict regulatory compliance, including adherence to GDPR. Growing interest in researching rare diseases and population-specific health conditions is driving demand for secure, reliable sample storage and processing solutions. Laboratories across Europe are increasingly adopting automated systems to improve operational efficiency and minimize errors. Collaborative efforts among universities, hospitals, and private companies are also accelerating the development and implementation of advanced sample handling technologies.

North America Region Dominates the Market with Major Share

The North American biological sample handling market is expanding with the growing investment in biomedical research and life sciences. This region has a solid healthcare system, and there are leading research universities and laboratories. An increase in biomedical research includes much need for more accurate, safer, and efficient ways to handle biological specimens both in the clinical and the drug development setting. Regulations that require tracking biological samples and integrating electronic data management, as well as the recent increase in concern for biological material safety, are adding more emphasis to better systems of handling biological materials. For instance, Thermo Fisher Scientific offers a new sample handling tool that is quickly growing in mainstream use in the research laboratory space. There is a growing interest in personalized medicine and genomic research to increase market growth. The use of robots and automation is increasingly preferred when handling high-volume samples. There is financial support from government grants, and collaboration between industry and research groups is likely to further develop and maintain growth in this market.

Market Players Outlook

The major companies operating in the global biological sample handling market include BD (Becton, Dickinson and Company), Bio-Rad Laboratories, Inc., Merck KGaA, QIAGEN GmbH, and Thermo Fisher Scientific Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

In June 2025, the International Seabed Authority (ISA) introduced the Deep-Sea Biobank Initiative (DBI) to facilitate access to biological samples and genetic data from the deepest part of the international seabed area beyond national jurisdiction (the Area). The DBI was announced on the margins of the third United Nations Ocean Conference in Nice, France, during a high-level event that brought together government leaders, regional and international organizations, scientists, and private companies.
In February 2025, Ahlstrom, in fiber-based specialty materials, announced that its biological sample collection cards have been officially listed as FDA Class 1 medical devices. This classification by the US Food and Drug Administration affirms the safety, reliability, and compliance of GenSaver 2.0, GenSaver Color 2.0, AutoCollect, 5 circles, BioSample, HemaSep Strip, HemaSep Punch, and Lipid Saver sample collection cards with the highest industry standards.

The Report Covers:

Market value data analysis of 2024 and forecast to 2035.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global biological sample handling market. Based on the availability of data, information related to new products and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2023338

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Global Biological Sample Handling Market Sales Analysis - Storage Type | Application | Ownership ($ Million)
Biological Sample Handling Market Sales Performance of Top Countries
1.1. Research Methodology
Primary Research Approach
Secondary Research Approach
1.2. Market Snapshot

2. Market Overview and Insights

2.1. Scope of the Study
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Biological Sample Handling Industry Trends
- 2.2.2. Market Recommendations
2.3. Porter's Five Forces Analysis for the Biological Sample Handling Market
- 2.3.1. Competitive Rivalry
- 2.3.2. Threat of New Entrants
- 2.3.3. Bargaining Power of Suppliers
- 2.3.4. Bargaining Power of Buyers
- 2.3.5. Threat of Substitutes

3. Market Determinants

3.1. Market Drivers
- 3.1.1. Drivers For the Global Biological Sample Handling Market: Impact Analysis
3.2. Market Pain Points and Challenges
- 3.2.1. Restraints For the Global Biological Sample Handling Market: Impact Analysis
3.3. Market Opportunities
- 3.3.1. Opportunities For the Global Biological Sample Handling Market: Impact Analysis

4. Competitive Landscape

4.1. Competitive Dashboard - Biological Sample Handling Market Revenue and Share by Manufacturers
Biological Sample Handling Product Comparison Analysis
Top Market Player Ranking Matrix
4.2. Key Company Analysis
- 4.2.1. BD (Becton, Dickinson and Company)
  - 4.2.1.1. Overview
  - 4.2.1.2. Product Portfolio
  - 4.2.1.3. Financial Analysis (Subject to Data Availability)
  - 4.2.1.4. SWOT Analysis
  - 4.2.1.5. Business Strategy
- 4.2.2. Bio-Rad Laboratories, Inc.
  - 4.2.2.1. Overview
  - 4.2.2.2. Product Portfolio
  - 4.2.2.3. Financial Analysis (Subject to Data Availability)
  - 4.2.2.4. SWOT Analysis
  - 4.2.2.5. Business Strategy
- 4.2.3. Merck KGaA
  - 4.2.3.1. Overview
  - 4.2.3.2. Product Portfolio
  - 4.2.3.3. Financial Analysis (Subject to Data Availability)
  - 4.2.3.4. SWOT Analysis
  - 4.2.3.5. Business Strategy
- 4.2.4. QIAGEN GmbH
  - 4.2.4.1. Overview
  - 4.2.4.2. Product Portfolio
  - 4.2.4.3. Financial Analysis (Subject to Data Availability)
  - 4.2.4.4. SWOT Analysis
  - 4.2.4.5. Business Strategy
- 4.2.5. Thermo Fisher Scientific Inc.
  - 4.2.5.1. Overview
  - 4.2.5.2. Product Portfolio
  - 4.2.5.3. Financial Analysis (Subject to Data Availability)
  - 4.2.5.4. SWOT Analysis
  - 4.2.5.5. Business Strategy
4.3. Top Winning Strategies by Market Players
- 4.3.1. Merger and Acquisition
- 4.3.2. Product Launch
- 4.3.3. Partnership And Collaboration

5. Global Biological Sample Handling Market Sales Analysis by Storage Type ($ Million)

5.1. Cold Storage
5.2. Room Temperature Storage

6. Global Biological Sample Handling Market Sales Analysis by Application ($ Million)

6.1. Drug Discovery
6.2. Forensic Investigation
6.3. DNA Extraction
6.4. Proteomics and Genomics Studies
6.5. Others

7. Global Biological Sample Handling Market Sales Analysis by Ownership ($ Million)

7.1. Commercial
7.2. Academic/Research

8. Regional Analysis

8.1. North American Biological Sample Handling Market Sales Analysis - Storage Type | Application | Ownership | Country ($ Million)
Macroeconomic Factors for North America
- 8.1.1. United States
- 8.1.2. Canada
8.2. European Biological Sample Handling Market Sales Analysis - Storage Type | Application | Ownership | Country ($ Million)
Macroeconomic Factors for Europe
- 8.2.1. UK
- 8.2.2. Germany
- 8.2.3. Italy
- 8.2.4. Spain
- 8.2.5. France
- 8.2.6. Russia
- 8.2.7. Rest of Europe
8.3. Asia-Pacific Biological Sample Handling Market Sales Analysis - Storage Type | Application | Ownership | Country ($ Million)
Macroeconomic Factors for Asia-Pacific
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
- 8.3.4. India
- 8.3.5. Australia & New Zealand
- 8.3.6. ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- 8.3.7. Rest of Asia-Pacific
8.4. Rest of the World Biological Sample Handling Market Sales Analysis - Storage Type | Application | Ownership | Country ($ Million)
Macroeconomic Factors for the Rest of the World
- 8.4.1. Latin America
- 8.4.2. Middle East and Africa

9. Company Profiles

9.1. Askion GmbH
- 9.1.1. Quick Facts
- 9.1.2. Company Overview
- 9.1.3. Product Portfolio
- 9.1.4. Business Strategies
9.2. Avantor, Inc.
- 9.2.1. Quick Facts
- 9.2.2. Company Overview
- 9.2.3. Product Portfolio
- 9.2.4. Business Strategies
9.3. Azenta Life Sciences (Brooks Life Sciences)
- 9.3.1. Quick Facts
- 9.3.2. Company Overview
- 9.3.3. Product Portfolio
- 9.3.4. Business Strategies
9.4. Beckman Coulter, Inc.
- 9.4.1. Quick Facts
- 9.4.2. Company Overview
- 9.4.3. Product Portfolio
- 9.4.4. Business Strategies
9.5. Becton, Dickinson and Company (BD)
- 9.5.1. Quick Facts
- 9.5.2. Company Overview
- 9.5.3. Product Portfolio
- 9.5.4. Business Strategies
9.6. Biocision, LLC (SelectScience)
- 9.6.1. Quick Facts
- 9.6.2. Company Overview
- 9.6.3. Product Portfolio
- 9.6.4. Business Strategies
9.7. Bio-Rad Laboratories, Inc.
- 9.7.1. Quick Facts
- 9.7.2. Company Overview
- 9.7.3. Product Portfolio
- 9.7.4. Business Strategies
9.8. Brooks Automation, Inc.
- 9.8.1. Quick Facts
- 9.8.2. Company Overview
- 9.8.3. Product Portfolio
- 9.8.4. Business Strategies
9.9. Clinfinite Solutions
- 9.9.1. Quick Facts
- 9.9.2. Company Overview
- 9.9.3. Product Portfolio
- 9.9.4. Business Strategies
9.10. Cryoport Systems, LLC
- 9.10.1. Quick Facts
- 9.10.2. Company Overview
- 9.10.3. Product Portfolio
- 9.10.4. Business Strategies
9.11. Discovery Life Sciences
- 9.11.1. Quick Facts
- 9.11.2. Company Overview
- 9.11.3. Product Portfolio
- 9.11.4. Business Strategies
9.12. Eppendorf SE
- 9.12.1. Quick Facts
- 9.12.2. Company Overview
- 9.12.3. Product Portfolio
- 9.12.4. Business Strategies
9.13. GenTegra LLC
- 9.13.1. Quick Facts
- 9.13.2. Company Overview
- 9.13.3. Product Portfolio
- 9.13.4. Business Strategies
9.14. Greiner Bio-One International GmbH
- 9.14.1. Quick Facts
- 9.14.2. Company Overview
- 9.14.3. Product Portfolio
- 9.14.4. Business Strategies
9.15. Hamilton Co.
- 9.15.1. Quick Facts
- 9.15.2. Company Overview
- 9.15.3. Product Portfolio
- 9.15.4. Business Strategies
9.16. LabVantage Solutions, Inc.
- 9.16.1. Quick Facts
- 9.16.2. Company Overview
- 9.16.3. Product Portfolio
- 9.16.4. Business Strategies
9.17. LabWare, Inc.
- 9.17.1. Quick Facts
- 9.17.2. Company Overview
- 9.17.3. Product Portfolio
- 9.17.4. Business Strategies
9.18. Merck KGaA
- 9.18.1. Quick Facts
- 9.18.2. Company Overview
- 9.18.3. Product Portfolio
- 9.18.4. Business Strategies
9.19. Promega Corp.
- 9.19.1. Quick Facts
- 9.19.2. Company Overview
- 9.19.3. Product Portfolio
- 9.19.4. Business Strategies
9.20. QIAGEN GmbH
- 9.20.1. Quick Facts
- 9.20.2. Company Overview
- 9.20.3. Product Portfolio
- 9.20.4. Business Strategies
9.21. Sartorius AG
- 9.21.1. Quick Facts
- 9.21.2. Company Overview
- 9.21.3. Product Portfolio
- 9.21.4. Business Strategies
9.22. Standard BioTools Inc. (Fluidigm Corp.)
- 9.22.1. Quick Facts
- 9.22.2. Company Overview
- 9.22.3. Product Portfolio
- 9.22.4. Business Strategies
9.23. Tecan Trading AG
- 9.23.1. Quick Facts
- 9.23.2. Company Overview
- 9.23.3. Product Portfolio
- 9.23.4. Business Strategies
9.24. Thermo Fisher Scientific Inc.
- 9.24.1. Quick Facts
- 9.24.2. Company Overview
- 9.24.3. Product Portfolio
- 9.24.4. Business Strategies
9.25. SPT Labtech Ltd
- 9.25.1. Quick Facts
- 9.25.2. Company Overview
- 9.25.3. Product Portfolio
- 9.25.4. Business Strategies
9.26. Zymo Research Corp.
- 9.26.1. Quick Facts
- 9.26.2. Company Overview
- 9.26.3. Product Portfolio
- 9.26.4. Business Strategies